Spotlight
Clinical Role
Clinical
Supplement Spotlight
CE
Subscribe
Biosimilars in Specialty Pharmacy: Navigating Approvals, Enhancing Care, and Optimizing Integration : Episode 5
Key Factors to Consider when Switching to Biosimilars
Dr Humphreys discusses key factors to consider when switching to biosimilars.
EP: 1.Comparing Biologics and Biosimilars
EP: 2.Biosimilar Utilization and Inventory Management
EP: 3.Operationalizing Biosimilars in Specialty Pharmacies
EP: 4.Advice for States that Require Prior Prescriber Approval for Substitution
Now Viewing
EP: 5.Key Factors to Consider when Switching to Biosimilars
Video content above is prompted by the following:
- To what extent should the pharmacy team prioritize supporting the switch from a reference product to a biosimilar, and what factors should be considered in making this decision?
Recent Videos
Related Content
